RBOT — Vicarious Surgical Cashflow Statement
0.000.00%
- $49.06m
- -$0.04m
- 18
- 30
- 45
- 21
Annual cashflow statement for Vicarious Surgical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -12.9 | -35.2 | 5.16 | -71.1 | -63.2 |
Depreciation | |||||
Non-Cash Items | 0.448 | 0.638 | -70.8 | 8.89 | 12.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.232 | 0.955 | 3.36 | -1.98 | -1.6 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -12 | -33.3 | -61.2 | -62.3 | -50 |
Capital Expenditures | -0.12 | -1.29 | -5.35 | -1.67 | -0.18 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 13.3 | — | — | -44.1 | 7.04 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 13.2 | -1.29 | -5.35 | -45.8 | 6.86 |
Financing Cash Flow Items | — | 190 | -0.3 | -2.82 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 13.5 | 192 | 9.14 | 44.7 | 0.008 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 14.7 | 158 | -57.4 | -63.4 | -43.1 |